Skip to main content
SSY Group Limited logo

SSY Group Limited — Investor Relations & Filings

Ticker · 2005 ISIN · KYG8406X1034 HKEX Manufacturing
Open in API
Filings indexed 1,216 across all filing types
Latest filing 2014-09-19 AGM Information
Country HK Hong Kong
Listing HKEX 2005

About SSY Group Limited

http://www.ssygroup.com.hk

SSY Group Limited is an investment holding company specializing in the research, development, manufacturing, and sale of pharmaceutical products. The Group is a prominent manufacturer, with a core focus on producing a wide range of intravenous infusion solutions and finished drugs. Complementing its pharmaceutical offerings, the company also manufactures essential packaging materials, including non-PVC soft bags and PP plastic containers. SSY Group supplies its comprehensive product line, which often utilizes green production technologies aimed at reducing costs and power consumption, primarily to hospitals and medical institutions.

Recent filings

Filing Released Lang Actions
NOTICE OF EXTRAORDINARY GENERAL MEETING
AGM Information Classification · 95% confidence The document is a notice of an Extraordinary General Meeting (EGM) for Lijun International Pharmaceutical (Holding) Co., Ltd. It includes details about the meeting date, location, agenda items including approval of a disposal agreement, authorization of directors, and declaration of a special dividend. The document is a formal announcement inviting shareholders to attend and vote at the meeting, with procedural notes on proxy appointments and voting rights. There are no financial statements, management discussion, or detailed financial data presented. The document is not a report but a meeting notice. Therefore, it fits the category of AGM Information (AGM-R), which includes presentations and materials shared during general meetings, including notices of meetings.
2014-09-19 English
FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING (THE "EGM") TO BE HELD ON 10 OCTOBER 2014 (FRIDAY) AT 2:00 P.M.
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Form of Proxy for an Extraordinary General Meeting (EGM) scheduled on 10 October 2014. It includes instructions for shareholders to appoint proxies to vote on resolutions, specifically regarding approval of a disposal agreement and declaration of a special dividend. The document is procedural and related to voting arrangements for a shareholder meeting, not the meeting materials themselves or the voting results. It is not a report, financial statement, or announcement of results. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings.
2014-09-19 English
MAJOR AND CONNECTED TRANSACTION - DISPOSAL OF ENTIRE ISSUED SHARE CAPITAL OF XI'AN LIJUN PHARMACEUTICAL CO., LTD.
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular issued by Lijun International Pharmaceutical (Holding) Co., Ltd. regarding a major and connected transaction involving the disposal of the entire issued share capital of a subsidiary company. It includes detailed information such as definitions, letters from the board, independent financial adviser, independent board committee, financial information of the group, general information, and a notice of an extraordinary general meeting (EGM) to approve the transaction. The document is comprehensive, over 15,000 characters, and contains substantive financial and transaction details. It is not merely an announcement or a proxy solicitation but a detailed circular providing information for shareholder approval of a major transaction. This type of document is best classified as a Proxy Solicitation & Information Statement (PSI), as it is sent to shareholders to provide information and request votes for the EGM related to the disposal transaction.
2014-09-19 English
2014 INTERIM REPORT
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report 2014' and contains detailed financial and operational information for the six months ended 30 June 2014. It includes unaudited interim results, management discussion and analysis, sales data, dividend distribution, business review, and prospects for development. The content is comprehensive and includes actual financial figures and analysis for a period shorter than a full fiscal year. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2014
2014-09-19 English
BUSINESS UPDATE
Regulatory Filings Classification · 95% confidence The document is an announcement made pursuant to listing rules and securities ordinance, indicating a business update about obtaining production approvals for pharmaceutical products by a subsidiary. It is relatively short (3028 characters) and does not contain financial statements or detailed financial analysis. It is not an annual or interim report, nor a call transcript or earnings release. It is a regulatory announcement informing shareholders and investors about a business development. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2014-09-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2014
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/08/2014, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related activities. The content is focused on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a capital or shareholding update. Given the detailed nature of share capital movements and the monthly frequency, this fits best under the category 'Share Issue/Capital Change (SHA)', which covers announcements regarding new share issues, stock splits, or other capital changes. The document length is substantial and contains detailed data, so it is not merely an announcement of a report but the report itself. Therefore, the classification is SHA with high confidence.
2014-09-04 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.